RELY vs SAIC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
RELY exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust liquidity profile (Current Ratio 3.30). While the company is successfully transitioning to profitability with explosive YoY EPS growth and consistent earnings beats, it trades at a significant premium to its Graham Number ($5.36) and Intrinsic Value ($2.17). This valuation gap is partially mitigated by a low Forward P/E of 13.08, suggesting high expected earnings growth. However, aggressive insider selling totaling $195.56M creates a significant headwind that offsets the bullish analyst consensus.
SAIC presents a conflicted profile with a Piotroski F-Score of 4/9, indicating stable but non-improving financial health. The stock is currently trading at a significant premium to both its Graham Number ($76.85) and Intrinsic Value ($53.90), suggesting it is overvalued based on deterministic models. While the company maintains a strong ROE of 23.27% and a consistent track record of beating earnings estimates, this is offset by negative YoY revenue (-4.80%) and earnings growth (-6.20%). The bearish technical trend and high debt-to-equity ratio further temper the outlook.
Compare Another Pair
Related Comparisons
RELY vs SAIC: Head-to-Head Comparison
This page compares Remitly Global, Inc. (RELY) and Science Applications International Corporation (SAIC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.